You are here

Valeant CEO cuts outlook for 'distracted' company, shares dive

valeant.jpg
Valeant Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a "distracted organisation" with a debt-loaded balance sheet.

Bengaluru

VALEANT Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a "distracted organisation" with a debt-loaded balance sheet.

The maker of toenail fungus cream Jublia and anti-

sentifi.com

Market voices on:

Powered by GET.comGetCom